Pages that link to "Item:Q5715373"
From MaRDI portal
The following pages link to Two‐Dimensional Dose Finding in Discrete Dose Space (Q5715373):
Displaying 14 items.
- Bayesian phase I/II adaptively randomized oncology trials with combined drugs (Q641145) (← links)
- A Bayesian adaptive design in cancer phase I trials using dose combinations in the presence of a baseline covariate (Q1733138) (← links)
- Analysis of ``learn-as-you-go'' (LAGO) studies (Q2039787) (← links)
- Adaptive clinical trial designs for phase I cancer studies (Q2452091) (← links)
- Continual Reassessment Method for Partial Ordering (Q2893418) (← links)
- A Hierarchical Bayesian Design for Phase I Trials of Novel Combinations of Cancer Therapeutic Agents (Q3064270) (← links)
- A Latent Contingency Table Approach to Dose Finding for Combinations of Two Agents (Q3183236) (← links)
- Semiparametric Dose Finding Methods for Partially Ordered Drug Combinations (Q5041342) (← links)
- A Parallel Phase I/II Clinical Trial Design for Combination Therapies (Q5459586) (← links)
- Flexible use of copula‐type model for dose‐finding in drug combination clinical trials (Q6055718) (← links)
- Adaptive Bayesian phase I clinical trial designs for estimating the maximum tolerated doses for two drugs while fully utilizing all toxicity information (Q6085905) (← links)
- A nonparametric Bayesian method for dose finding in drug combinations cancer trials (Q6626759) (← links)
- Bayesian optimization design for finding a maximum tolerated dose combination in phase I clinical trials (Q6637076) (← links)
- Dual-agent dose-finding in phase I clinical trial -- an extension of rapid enrollment design (Q6652600) (← links)